It was not until this time that Dr Lane was given formal authority to proceed to tender with MARP01, the name given to the stop-gap proposal. Read more about It was not until this time that Dr Lane was given formal authority to proceed to tender with MARP01, the name given to the stop-gap proposal.
Dr Lane was authorised to proceed with the stop-gap project. The DHSS anticipated that the sum of £750,000 would be available for the capital development of BPL in 1980/1981. Read more about Dr Lane was authorised to proceed with the stop-gap project. The DHSS anticipated that the sum of £750,000 would be available for the capital development of BPL in 1980/1981.
Ministers decided to defer the eventual decision on whether to build a new laboratory within the NHS until other possibilities had been investigated. Read more about Ministers decided to defer the eventual decision on whether to build a new laboratory within the NHS until other possibilities had been investigated.
At a meeting of the Scientific and Technical Committee for the Central Blood Laboratories, members did not support commercial development, and recommended that no time should be lost in planning for a completely new NHS plant. Read more about At a meeting of the Scientific and Technical Committee for the Central Blood Laboratories, members did not support commercial development, and recommended that no time should be lost in planning for a completely new NHS plant.
R Smart published a report titled "Blood Products Laboratory: Redevelopment". Read more about R Smart published a report titled "Blood Products Laboratory: Redevelopment".
A NBTS meeting was held when it became apparent that any further plasma provided to BPL for fractionation would have to be dealt with in "unsatisfactory accommodation". Read more about A NBTS meeting was held when it became apparent that any further plasma provided to BPL for fractionation would have to be dealt with in "unsatisfactory accommodation".
Ministers continued to stress the need for collaboration between Scotland and England in manufacturing blood products. Read more about Ministers continued to stress the need for collaboration between Scotland and England in manufacturing blood products.
A Working Party on Human AHG meeting debated where the preparation of AHG should take place. Read more about A Working Party on Human AHG meeting debated where the preparation of AHG should take place.
By 1976, 46% of donations in Scotland were issued as red cell concentrates. By 1982, 60% of donations were being processed into red cell concentrates with 200ml of plasma removed. Read more about By 1976, 46% of donations in Scotland were issued as red cell concentrates. By 1982, 60% of donations were being processed into red cell concentrates with 200ml of plasma removed.
Dr Biggs wrote to Dr Waiter discussing seeking an increase in the supplies of commercially produced concentrates. Read more about Dr Biggs wrote to Dr Waiter discussing seeking an increase in the supplies of commercially produced concentrates.